Status:
RECRUITING
Sarcopenia in Older Patients in the Acute Hospital Setting
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Sarcopenia
Frailty
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
This study will assess whether the use of technology using the Virtual Gate Device (VGD) will prevent or minimize the development of hospital acquired Sarcopenia resulting from Immobilization.
Detailed Description
Modern advances in prevention, medical care, and treatments have resulted in an ever-increasing life expectancy and aging of the population. As a result, it is imperative that health care professional...
Eligibility Criteria
Inclusion
- Male and female patients 75 years of age and older.
- Patients admitted with an acute infection (clinically from a respiratory or urinary source).
- Expected length of hospitalization of at least 4 days.
- Patients who are conscious and cognitively able to provide written informed consent as determined by a score of 0 on the 4AT scale
Exclusion
- Male and female patients under 75 years of age.
- Expected length of hospitalization of less than 4 days.
- A condition limiting the use of the virtual gate device (VGD) due to factors relating to discomfort or safety, including but not limited to: fracture, amputation, local infection, pain, paralysis of one or both lower limbs, cardiac arrhythmia or cardiac pacemaker.
- Patients who are unable to or do not provide informed consent for participation.
- A score 1 or more on the 4AT scale.
Key Trial Info
Start Date :
April 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04092790
Start Date
April 18 2021
End Date
June 30 2025
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, North, Israel, 3109601